Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome.

Saved in:
Bibliographic Details
Title: Development of a set of bacterial engineered glycoconjugates as novel serogroup-specific antigens for the serodiagnosis of Escherichia coli O26, O111, O103 and O45 infections associated to hemolytic uremic syndrome.
Authors: Caillava, Ana J.1 (AUTHOR), Melli, Luciano J.1 (AUTHOR), Landoni, Malena2 (AUTHOR), Landivar, Stella Maris1 (AUTHOR), Chinen, Isabel3 (AUTHOR), Couto, Alicia S.2 (AUTHOR), Rivas, Marta4,5 (AUTHOR), Ugalde, Juan E.1 (AUTHOR), Comerci, Diego J.1 (AUTHOR), Ciocchini, Andrés E.1 (AUTHOR) aciocchini@iibintech.com.ar
Source: Microbial Cell Factories. 5/20/2025, Vol. 24 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752859
DOI:10.1186/s12934-025-02694-0